Combination Products
According to one survey, an estimated 30% of products under development are such "combo" products. The convergence of drugs/biologics and devices brings a host of regulatory challenges.* ChallengesCombination products are Class III devices which require a thorough assessment procedure. Because of their complexity and risk, not all Notified Bodies can assess combination products, which may be subject to additional directives if devices incorporate a substance of animal origin (if considered a risk of transmissible spongiform encephalopathies) or human blood derivatives. Determining a device's status, whether it is a drug or medical device, depends upon its primary mode of action. This can be a difficult determination involving not just the Notified Body, but also the Competent Authority and the European Commission. Your selection of a credible, respected Notified Body is critical, so that you can have confidence in their assessments and collaboration with other organizations. LNE/G-MED has significant experience with various families of combination products and can call on experts in biological and viral safety when necessary to certify products. AdvantagesLNE/G-MED is recognized to assess Active Implantable Medical Devices and has significant experience certifying a wide range of devices for CE Marking, often in conjunction with ISO 13485, CMDCAS, third party FDA inspection and other certificates, to save the time and cost of multiple audits. You also benefit from:
Find Out MoreLNE/G-MED America offers in-person, online and other customized training on a wide range of certification and quality topics. For details, check out our training schedule or request a customized program.
*Source: Stephen Ritcher, Ph.D, Combination Products: Navigating Two FDA Quality Systems, PharmaManufacturing.com: accessed online on March 28, 2010 |





- Progress Report - News
- EC Publishes E-Labeling Regulation
- IVD Updates
- Post-Market Phase
- IEC 60601 3rd Edition
- Tech File Evaluation
- Clinical Evaluation
- Recast of IVD Directive
- Own Brand Label Devices
- Software Engineering
- Med. Device Packaging
- Single Use Devices
- Usability Engineering
- FDA Use of ISO 13485
- Risk Management
- IVD Directive
- Switching Notified Body
- Regulatory News
- Ask Our Experts
- Free Guide: CE Marking
- Free Guide: IEC 60601 3rd Edition
- Free Guide: EMC Testing
- Free Guide: IVD
- Free Guide: Brazil MD Approval
- Technical FAQs
- Progress Report - News



Although the notion of Combination Products under U.S regulations can be broad, the EU medical directives cover essentially three configurations:
